Ault Milton C III - Sep 19, 2025 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director, 10%+ Owner
Signature
/s/ Milton C. Ault, III
Stock symbol
ALZN
Transactions as of
Sep 19, 2025
Transactions value $
-$180,856
Form type
4
Date filed
9/23/2025, 04:30 PM
Previous filing
Sep 19, 2025
Next filing
Sep 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
AULT MILTON C III Director, 10%+ Owner 11411 SOUTHERN HIGHLANDS PARKWAY, SUITE 190, LAS VEGAS /s/ Milton C. Ault, III 2025-09-23 0001212502

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Sale -$181K -77K -90.31% $2.35 8.26K Sep 19, 2025 By Ault Lending, LLC F1
transaction ALZN Common Stock Conversion of derivative security $232K +100K +1210.65% $2.32 108K Sep 22, 2025 By Ault Lending, LLC F1, F2
holding ALZN Common Stock 1.84K Sep 19, 2025 Direct
holding ALZN Common Stock 11.1K Sep 19, 2025 By Ault Life Sciences, Inc. F3
holding ALZN Common Stock 61 Sep 19, 2025 By Ault Life Sciences Fund, LLC F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Series B Convertible Preferred Stock Conversion of derivative security -$232K -232 -17.8% $1,000.00 1.07K Sep 22, 2025 Common Stock 100K $2.32 By Ault Lending, LLC F1, F5, F6
holding ALZN Common Stock Purchase Warrants 13.6K Sep 19, 2025 Common Stock 13.6K $108.00 By Ault Lending, LLC F1
holding ALZN Common Stock Purchase Warrants 8.67K Sep 19, 2025 Common Stock 8.67K $108.00 By Ault Lending, LLC F1
holding ALZN Common Stock Purchase Warrants 1.11K Sep 19, 2025 Common Stock 1.11K $108.00 By Ault Lending, LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F2 Represents shares of common stock received upon conversion of Series B convertible preferred stock ("Series B Preferred").
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
F5 The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock.
F6 The shares of Series B Preferred have no expiration date.